News
Explore the latest stories and publications from NCATS and our partners, see upcoming events, or explore the variety of resources we provide to better understand translational science and our work.
News
Read the latest news from NCATS and its collaborators whose research is supported through the Center’s programs, or follow coverage of NCATS' translational research activities through national and local media.
New Study Reveals Gut Microbiome as Key Predictor of IBS Treatment Response
April 22, 2026 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
Reminiscing May Ease Grief When Caring for People With Dementia
April 22, 2026 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
Grant Money Available to Reduce Health Disparities
June 27, 2022 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
Factors Causing Low COVID-19 Vaccination Have Spilled Over to Lower Flu Vaccination Rates, Study Finds
June 15, 2022 - Media Coverage
- Clinical and Translational Science Awards (CTSA) Program
Using AI to Advance Understanding of Long COVID Syndrome
June 7, 2022 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
The COVID-19 pandemic continues to present considerable public health challenges in the United States and around the globe. One of the most puzzling is why many people who get over an initial and often relatively mild COVID illness later develop new and potentially debilitating symptoms. These symptoms run the gamut including fatigue, shortness of breath, brain fog, anxiety, and gastrointestinal trouble.
The National COVID Cohort Collaborative (N3C), a national, publicly available data resource sponsored by NCATS, is part of NIH’s Researching COVID to Enhance Recovery (RECOVER) initiative, which aims to improve understanding of Long COVID.
Study Finds Immune Dysfunction Is a Significant Risk Factor for COVID-19 Breakthrough Infection
June 3, 2022 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
The National COVID Cohort Collaborative Data Enclave helps researchers identify a link between COVID-19 breakthrough infections and people with abnormal or impaired immune systems.
Immune Modulator Drugs Improved Survival for People Hospitalized with COVID-19
June 2, 2022 - NCATS News
- COVID-19
- Clinical and Translational Science Awards (CTSA) Program
A large NCATS-coordinated, randomized, placebo-controlled clinical trial showed that treating adults hospitalized with COVID-19 with infliximab or abatacept — drugs widely used to treat certain autoimmune diseases — substantially improved clinical status and reduced deaths but did not significantly shorten time to recovery.
Hydrocortisone Does Not Prevent Lung Complication in Extremely Preterm Infants
March 23, 2022 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
Hydrocortisone is no more effective than placebo at preventing damage that can result from oxygen and ventilator therapy necessary to keep preterm infants alive, according to research supported in part by NCATS. The study of a potential treatment for the condition, known as bronchopulmonary dysplasia, appears in The New England Journal of Medicine.